miR‑590‑5p suppresses osteosarcoma cell proliferation and invasion via targeting KLF5

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA (miR)-590-5p exhibits tumor-suppressive roles in colorectal and breast cancers.
• The specific function of miR-590-5p in osteosarcoma (OS) remains largely unexplored.
• Understanding miR-590-5p's role is crucial for developing novel therapeutic strategies for OS.

Purpose of the Study:

• To investigate the expression and function of miR-590-5p in osteosarcoma.
• To identify the molecular targets of miR-590-5p in OS progression.
• To evaluate the therapeutic potential of the miR-590-5p/KLF5 axis in OS treatment.

Main Methods:

• Quantitative real-time PCR to assess miR-590-5p expression in OS tissues and cell lines.
• In vitro assays (proliferation, migration, invasion) to evaluate the functional impact of miR-590-5p.
• In vivo tumor xenograft models to assess miR-590-5p's effect on tumor growth.
• Luciferase reporter assays and Western blotting to confirm direct targeting of KLF5 by miR-590-5p.

Main Results:

• miR-590-5p was significantly downregulated in osteosarcoma samples and cell lines compared to normal controls.
• Overexpression of miR-590-5p suppressed osteosarcoma cell proliferation, migration, and invasion in vitro and inhibited tumor growth in vivo.
• miR-590-5p directly targeted Kruppel-like factor 5 (KLF5), with inverse correlation observed in OS tissues.
• Restoration of KLF5 expression abrogated the inhibitory effects of miR-590-5p, confirming KLF5 as a key downstream mediator.

Conclusions:

• The miR-590-5p/KLF5 signaling pathway plays a critical role in regulating osteosarcoma progression.
• miR-590-5p acts as a tumor suppressor in osteosarcoma by inhibiting cell proliferation, migration, and invasion via KLF5.
• The miR-590-5p/KLF5 axis represents a promising novel therapeutic target for osteosarcoma treatment.